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Our patient 
■ L. O. V.
■ Male
■ 62 years old
■ Retired (Railway attendant by profession)
■ A townsman
■ Date of admission: November 14
Complains
■Dyspnea (mixed) during exercise and at rest.
■Cough
■Fatigue
■Palpitations
■Chest pain into the right side of the chest at rest and during physical activity
■Heaviness in the legs at night, after physical activity and after long sedentary 
period.
Medical history
■ Dyspnea with cough with transparent sputum appeared a month ago
■ There was no treatment for the dyspnea during this period 
■ On November 14 2015, the condition was deteriorated and the dyspnea became 
more severe with cough, fatigue ,palpitations and this symptoms disturbed the 
patient even at rest
■ He noted varicose veins in both lower limbs two years ago and he associated it 
with long term standing
■ A month ago he noticed localized redness of limb in the right lower limb and he 
didn’t seek treatment
■ He was admitted in the 5th central clinical hospital
Life history
■ For 12 years (since 2003), patient has had arterial hypertension (maximum 
200/150 mm hg).
■ He has no history of stomach or duodenal ulcer, tuberculosis, diabetes, 
sexually transmitted diseases, viral hepatitis, rheumatism, mental illness.
■ Family history is not burdened.
■ Allergic history is not burdened 
■ He has not had any previous surgical operations
■ Smoking history :for 40 years he smokes a pack of cigarette or 2 per day. 
(pack/cig index= 40 pack year smoking index)
Objective status (14 Nov 2015)
The general condition is satisfactory, consciousness is clear, emotionally stable, optimistic mood.
Normosthenic physique. Height -1.7m. Weight -70kg. BMI- 24.2 (normal).
There is peripheral edema in the right tibia. There is no peripheral edema into the left lower limb. 
There are dilated superficial veins in the both lower limbs, redness of the skin in the inner surface 
of the right tibia. 
Respiratory System: Pulmonary percussion:- dullness on the right side of the chest. Dullness was 
heard on the IV to VI intercostal space on the posterior axillary line.
Auscultation - vesicular breathing over all the surface of the lungs but there is wheezing into the 
right side of the chest(posterior axillary line ) 
Cardiovascular system- accent of 2nd tone of aorta, murmur into the pulmonary artery. Pulse is 
equal to heart rate at 66 beats/min. Blood pressure is 160/100 mmHg on both hands
Kidney sign is negative on both sides.
Abdomen is soft and painless during palpation.
There is enlargement of the liver by 2 cm below the ribs. 
Plan of survey
1. Complete blood count 
2. Biochemical blood profile
3. Chest X ray 
4. ECG
5. Ultrasound of the heart 
6. Ultrasound of the vessels of the lower limbs 
Additional recommended 
1. Blood lipid profile 
2. Coagulogram
3. CT scan
4. D dimer test
5. Holter ECG
6. Urinalysis 
Complete blood count
■ The blood test are without any changes 
INDEX RESULT NORMAL
hemoglobin 138g/l 120-140g/l
erythrocytes 4.52 3.9-4.7
CPU 1.0 0.85-1.15
hematocrit 39.8% 36-42%
thrombocytes 170g/l 160-320g/l
leukocytes 6.3g/l 4.0-9.0 g/l
Stab cells 3% 1-6%
segmented 54.5% 47-72%
eosinophils 3% 0.5-5.0%
basophils 0.9% 0-1.0%
lymphocytes 26% 19-37%
monocytes 7.2% 3-11%
ESR 8mm/h 2-15mm/h
Summary:- there are no changes in the blood
Biochemical blood analysis
Index Result normal range
Glucose 5.71mmol/l 3.9-6.4 mmol/l
sodium 140mmol/l 136-146mmol/l
potassium 4.0mmol/l 3.5-5.1mmol/l
INR 1.32 2-3
Summary :- the INR is below the normal range according to 
the regime of the intake of anticoagulants.
X-ray of the chest (20 Nov 2015)
■ There are no infiltrative or local changes in the lung
■ There are signs of venous hypertension into the lungs (pulmonary hypertension)
■ The root of the lungs are dilated
■ The roots are extended due to vessel picture
■ The sinus are without liquid
■ There is dilation of heart in the left side 
■ There is sclerosis of aorta in the arch area.
Summary :- Lung hypertension, dilation of the heart on the left and sclerosis of the 
aorta
ECG of our patient 
Summary: sinus rhythm is correct, signs of left ventricle hyperthophy, QRS complex is normal, two-
humped P wave
Ultrasound of the heart
■ Left atrium is dilated, the diameter is 42.9mm (< 38 is normal)
■ End diastolic volume is 63.1mm (35-58mm)
■ End systolic volume is 49.2 mm (23-48mm)
■ Posterior wall of L.V 16.8 mm (6-11mm)
■ Cavity of L.V is dilated 
■ Intraventricular septum 16.6 mm (6-11mm)
■ R.V dilated 36.6 mm (9- 26mm)
■ R.A dilated 42.9mm 
Aortic valve,mitral valve and the aortic walls are sclerotic
Mitral valve, there is regurgitation of 1st degree
Aortic regurgitation of 1st degree
Ejection fraction 44% (55-78%) Lung hypertension of 2nd degree
Summary -: there are sclerotic changes of the aortic valve, mitral valve and aortic walls .There is also 
dilation of all heart cavities. There is regurgitation 1st degree of both mitral and aortic valves. There is 
evidence of lung hypertension of 2nd degree. Contractile ability of the heart is reduced

Ultrasound of vessels of lower limbs
■ superficial veins thrombophlebitis and valvular 
insufficiency into the right lower limb.
■ varicosis of veins of both lower limbs
Basic clinical syndromes 
■ Pulmonary embolism
■ Infarct pneumonia 
■ Thrombophlebitis
■ Varicose veins
■ Pulmonary hypertension
■ Arterial hypertension
■ Acute right ventricular insufficiency 
■ Congestive heart failure.
Classification of pulmonary embolism
massive - affects more than 50% of the volume of the vascular bed of the lungs 
(pulmonary embolism trunk and / or the main pulmonary artery) and the disease 
manifests shock and / or systemic hypotension;
submassive - affects up to 30 - 50% of the volume of the vascular bed of the lungs 
(embolism many more equity or segmental pulmonary arteries) and manifests 
symptoms of right ventricular failure;
nonmassive - struck less than 30% of the volume of the vascular bed of the lungs 
(pulmonary embolism small distal arteries), manifestations are absent or minimal 
(lung infarction).
Infarct Pneumonia
Pulmonary infarction is localized destruction 
(necrosis) of lung tissue by blocking 
(obstruction of) the arterial blood supply. 
Infarct pneumonia is infection of the infarcted
lung tissue.
Thrombophlebitis
Thrombophlebitis is partial or total occlusion of major veins which form in the 
presence of inflammation of the venous walls.
Classification according localization 
■ Superficial
■ Deep 
Classification according to degree of trophic changes and hemodynamical incompetence 
■ mild form 
■ moderate form 
■ severe form
Classification according to clinical course 
■ Acute thrombophlebitis
■ Subacute thrombophlebitis
■ Chronic thrombophlebitis (postphlebitic syndrome)
Varicose veins (chronic venous disorder)
Varicose veins are veins that have become enlarged and twisted.
Clinical, Etiological, Anatomical, and Pathophysiological (CEAP) classification for 
Varicose veins
No visible or palpable varicose veins
C1 -Telangectasia (Thread veins / Spider veins / Broken veins)
C2 is subdivided into 
C2A- Varicose veins without any symptoms (Asymptomatic)
C2S- Varicose veins with symptoms
C3- Swollen ankle (oedema) due to varicose veins or hidden varicose veins (venous reflux)
C4- Skin damage due to varicose veins or hidden varicose veins (venous reflux)
C5- Healed venous leg ulcer
C6 - Venous leg ulcer
Group 1'.
Pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillary haemangiomatosis (PCH)
Group 2.
Pulmonary hypertension due to left heart diseases
● Systolic dysfunction
● Diastolic dysfunction
● Valvular disease
Pulmonary hypertension classification 
according to WHO 2
Group 3 -: Pulmonary hypertension due to lung diseases and/or hypoxemia
Group 4 :-Chronic thromboembolic pulmonary hypertension (CTEPH)
Group 5 :- PH with unclear multifactorial mechanisms
■ Haematological disorders: myeloproliferative disorders, splenectomy
● Systemic disorders: sarcoidosis, pulmonary Langerhans cell histiocytosis, 
lymphangioleiomyomatosis, neurofibromatosis,vasculitis
● Metabolic disorders: glycogen storage disease, Gaucher disease, thyroid 
disorders
● Others: tumoral obstruction, fibrosing mediastinitis, chronic renal failure on 
dialysis
Clinical classification of hypertension in grades 
according to European society of cardiology
Category Systolic blood pressure (mm 
hg)
Diastolic blood pressure (mm 
hg)
Optimal blood pressure < 120 < 80
Normal blood pressure < 130 < 85
Normal blood pressure < 130 < 85
Mild hypertension (1 degree) 140-159 90-99
Moderate hypertension (2 
degree)
160-179 100-109
Severe hypertension (3 degree) >180 > 100
Isolated systolic hypertension >140 > 90
Classification of hypertension in stages with clinical 
features.
■ Stage 1: there are no injuries to target organs
■ Stage 2: there are damages to target organs without functional impairment. 
Heart : left ventricle hypertrophy. 
Eyes: retinopathy
Kidney :micro albuminuria or creatinine elevation less than 177 mmol/l              (100-
177mmol/l)
Brain: transient ischemic attack 
■ Stage 3: injuries of internal organ with functional impairment 
Heart- heart failure, myocardial infarction, valve dysfunction
Eyes –retinopathy with the disturbance of vision
Brain –stroke 
Liver –hepatomegaly
kidney- chronic kidney disease . Creatine (more than 177mmol/l)
protein in urine
Acute right ventricular insufficiency
Classification of heart failure according 
to the  ACC/AHA
Heart failure stage 
A
patient is at high risk of developing heart failure in the 
future but no functional or structural heart disorder
Heart failure stage 
B
Structural heart disorder but without symptoms of 
heart failure
Heart failure stage 
C
Structural heart disorder with prior or current 
symptoms of heart failure
Heart failure stage 
D
Refractory heart disorder requiring special 
interventions 
Classification of heart failure (according 
to New York heart association) 
Functional classification
Class Patient Symptoms
I
No limitation of physical activity. Ordinary physical activity does not 
cause undue fatigue, palpitation, dyspnea (shortness of breath).
II
Slight limitation of physical activity. Comfortable at rest. Ordinary 
physical activity results in fatigue, palpitation, dyspnea (shortness of 
breath).
III
Marked limitation of physical activity. Comfortable at rest. Less than 
ordinary activity causes fatigue, palpitation, or dyspnea.
IV
Unable to carry on any physical activity without discomfort. Symptoms 
of heart failure at rest. If any physical activity is undertaken, discomfort 
increases.
Classification of heart failure according 
to ejection fraction
By LVEF (left ventricle ejection fraction.)
Classification Ejection fraction
I.Heart failure with reduced ejection fraction 
(HFrEF)
< or = 40%
II.Heart failure with preserved ejection fraction 
(HFpEF)
> or = 50%
Clinical diagnosis 
Main: Pulmonary embolism. Infarct pneumonia. Arterial 
hypertension (2nd degree and 2nd stage). Chronic heart failure 
IIA stage, II FC with abnormal ejection fraction (44%)
Associated disease: Right lower limb superficial vein 
thrombophlebitis. Varicose veins of both lower limbs
Management of patient 
 Lifestyle modification (quit smoking, continuous adherence to physical activity and diet
 Oxygen treatment 
 Clexcane (enoxaparin) -0.4mg (2.4% in 5ml) Warfarin after discharge from the hospital
 Bisoprolol (b-blocker) 10mg once daily.  
 Amlodipine (CCB) 10mg once daily
 Rosovalstatin (statins) 10mg/day
 Valsartan(angiotensin II)  160 mg
 Hydrochlorothiazide). 12.5 mg . 2 times a day.
 Cephalosporin -3rd generation to prevent development of pneumonia
 Euphylline (to reduce dyspnea) 5mg/kg
 Lasolvan (mucolytic) 30mg 3times a day for the first 2-3 days and then 30mg 2 times 
daily afterwards
Additional treatment
1.Lifestyle modification
■ the patient is advised to quit smoking
■ continuous adherence to physical activity and diet.
2. Drug therapy
■ Local therapy with ointment (heparin ointment)
■ Surgical treatment to remove varicose vein 
Specific diet in patients with warfarin
■ They should avoid meals with large amount of vitamin K as that could interfere with 
the mechanism of warfarin.
Meals like this should be avoided ;-
■ Kale
■ Spinach
■ Brussels sprouts
■ Parsley
■ Collard greens
■ Mustard greens
■ Chard
■ Green tea
Definition, frequency and clinical 
significance 
■ Thromboembolism of pulmonary artery (pulmonary embolism ) :- is a blockage 
of the lung's main artery or one of its branches by a substance that has traveled 
from elsewhere in the body through the bloodstream (embolism). 
■ 30% of patients die if untreated usually due to recurrent pulmonary embolism
–Up to 60% of autopsies will show some evidence of past PE
Epidemiology of pulmonary 
Embolism
– 90-95% of pulmonary emboli originate in the deep venous 
system of the lower extremities
– Other rare locations include
■ Uterine and prostatic veins
■ Upper extremities
■ Renal veins
■ Right side of the heart
Types of pulmonary embolism
■ Acute 
-massive (bp < 90/40 mmhg >15 mins 
-sub massive 
■ Chronic 
■ Saddle embolism 
-embolus lodges at the main P.A birufication  
Risk factors for pulmonary embolism
Virchow’s triad 
■ Rudolf Virchow postulated more than a century ago that a triad of factors predisposed to 
venous thrombosis
– Local trauma to the vessel wall
– Hypercoagulability
– Stasis of blood flow
Most patients who suffer a P.E have an underlying disposition until 
it gets triggered
Pathophysiology
■ Clot from deep veins of leg breaks off
■ Travels via venous system to right side of heart
■ Fragments in right side of heart
■ Showers lung with emboli varying in size
■ On average > 6-8 vessels are embolized
Pathogenesis 
■ When venous emboli become dislodged from their 
site of origin, they embolize to the pulmonary arterial 
circulation or, paradoxically to the arterial circulation 
through a patent foramen ovale.
– About 50% of patients with pelvic or proximal leg deep 
venous thrombosis have PE
– Isolated calf or upper extremity venous thrombosis pose 
a lower risk for PE
Risk factors for pulmonary embolism 1 
■ Superficial and deep vein thrombosis 
■ Inherited thrombophilia 
■ Smoking
■ Long bone fracture 
■ Long bed rest (after surgery or sedentary obese people)
■ Malignancy
■ Surgery 
■ Trauma
■ Oral contraceptives 
■ Obesity 
■ Pregnancy 
Risk factors for pulmonary embolism 2 
■ Orthopedic surgery 
■ Congestive heart failure
■ Sickle cell disease
■ Hypertension
■ Inflammatory bowel disease
■ Presence of central vein catheter
Signs and Symptoms of pulmonary 
embolism 
■ Dyspnea with rest or with movement 
■ Plueritic pain (pain with breathing)
■ Calf or thigh pain and swelling 
■ Cough 
■ Orthopnea
■ Wheezing 
■ Excessive sweating 
■ Cyanosis (blue colored skin )
■ Weak pulse 
■ Tachypnea , tachycardia , crackles, decreased breath sounds
■ Loud s2, raised jugular vein pressure 
Laboratory investigations 
■ Arterial blood gases (hypoxemia, hypocapnia, respiratory alkalosis, 
hypercapnia, respiratory and metabolic acidosis if massive) 
■ Troponin levels 
■ Complete blood count 
■ Clotting status (PT, aPTT, TT), and some screening tests (erythrocyte 
sedimentation rate, renal function, liver enzymes, electrolytes). 
D dimer
■ Fibrin degradation product found in a blood test 
■ It is elevated in most patient with P.E
■ Normal range is less than 250ng/ml
■ D-dimer is highly sensitive but not specific (specificity around 50%). In other 
words, a positive D-dimer is not synonymous with PE, but a negative D-dimer is, 
with a good degree of certainty, an indication of absence of a PE
■ It provides supporting evidence for the need for imaging
Imaging of P.E
■ Chest X-ray 
It is mostly abnormal but it doesn’t differentiate P.E from other diagnosis.
Radiologic signs include Hampton’s hump, fleischner sign, knuckle sign, westermark sign.
Hampton’s hump(wedge shaped infarct that can be found on x ray) 
VQ scan(ventilation perfusion scan) 
A lung ventilation/perfusion scan, or VQ scan, is a test that measures air and blood 
flow in a patient’s lungs. A VQ scan most often is used to help diagnose or rule out 
a pulmonary embolism
The ventilation scan shows where air flows in the lungs. The perfusion scan shows 
where blood flows in the lungs.
Both scans use radioisotopes (a low-risk radioactive substance). For the ventilation 
scan, the patient inhales a small amount of radioisotope gas. For the perfusion 
scan, the radioisotopes are injected into a vein in the arm.
Normal VQ scan virtually excludes PE
It is particularly useful in people who have an allergy to iodinated contrast, impaired 
renal function, or are pregnant (due to its lower radiation exposure as compared to 
CT)
VQ scan results
CT scan
■ CT pulmonary angiography (CTPA) is 
a pulmonary angiogram obtained 
using computed tomography (CT) with radio 
contrast rather than right heart catheterization.
■ Its advantages are its high specificity, rapidity, 
and diagnosis of other diseases
■ Its disadvantages are availability, expenses, and 
contrast load
CT SCAN 
Ultrasound of the legs (leg Doppler)
■ This is done in search of deep vein 
thrombosis . Absence of this doesn’t 
exclude the diagnosis of P.E but the 
presence of it could be enough to start 
anticoagulation therapy and this is 
particularly useful in pregnant women as this 
prevents risk to unborn child from radiologic 
methods.
Varicose vein Ultrasound. 
Wells criteria to determine DVT
Wells criteria to determine pretest 
probability
Management of Pulmonary Embolism
■ Anticoagulation therapy(main treatment)
Acute treatment 
1. Unfractionated heparin
2. Low molecular weight heparin 
3. fondaparinux
Chronic treatment 
1. Warfarin (use international normalized ratio to monitor)
2. Acenocoumarol or phenprocoumon (coumarin derivatives and vitamin k 
antagonists)
International normalized ratio
■ This blood test looks to see how well the patient's blood clots.
■ The international normalized ratio (INR) is a standardized number that's figured 
out in the lab. If a patient is on  blood thinners, also called anti-clotting drugs or 
anticoagulants, it's especially important to check the INR. The INR is figured out 
using the results of the prothrombin time (PT) test, which measures the time it 
takes for blood to clot. The INR is an international standard for the PT.
I.N.R
Thrombolysis
■ Indication 
-Massive PE (SBP <90 mmhg for >15mins)
Catheter-directed thrombolysis (CDT) is a new technique found to be relatively safe 
and effective for massive PEs. This involves accessing the venous system by 
placing a catheter into a vein in the groin and guiding it through the veins by using 
fluoroscopic imaging until it is located next to the PE in the lung circulation. 
Medication that breaks up blood clots is released through the catheter so that its 
highest concentration is directly next to the pulmonary embolus. CDT is performed 
by interventional radiologists, and in medical centers that offer CDT, it should be 
considered first-line treatment.
Controversial indication
■ Severe hypoxemia 
■ Large thrombus burden 
■ RV dysfunction 
■ Saddle embolus
■ Non massive P.E
Absolute contraindications
-intracranial neoplasm 
-recent (<3 months) intracranial surgery or ischemic stroke 
-hemorrhagic stroke 
-active or recent bleeding 
Relative contraindications
■ Bp> 180 systolic
■ h/o ischemic stroke 
■ Recent (<4 weeks) internal bleeding
■ thrombocytopenia
Thrombolytic agents
■ Tissue plasminogen activator (tpa)
- Alteplase
-Iv drip 100 mg over 2 hours 
-reteplase
-tenecteplase
■ Streptokinase
-IV drip 250,00 units over 30mins
-followed by 100,000 u/hr for 24 hours
■ urokinase
Side effects of thrombolysis
■ Bleeding  (intracranial hemorrhage )
■ Allergic reaction and hypotension to streptokinase 
Inferior vena cava filter
The advantages of using IVCF 
are if anticoagulant therapy is 
contraindicated or if the person 
still has a pulmonary embolus 
in spite of being 
anticoagulated. In these 
instances, it may be implanted 
to prevent new or existing 
DVTs from entering the 
pulmonary artery and 
combining with an existing 
blockage
Surgical embolectomy
■ Must be done by an experienced surgeon 
■ Requires cardiopulmonary bypass
■ Indicated as an alternative to thrombolysis or when 
thrombolysis is contraindicated.
Prevention of blood clots formation
■ Blood thinners to help prevent DVT in people at high risk
■ Pressure stockings for people who previously had a DVT or 
varicose veins. They will improve blood flow in the legs and reduce 
risk of blood clots .
■ Smoking cessation 
■ People who are at very high risk of blood clots may need shots 
heparin when they take long flights 
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